Omkar Pharmachem Ltd logo

Omkar Pharmachem Ltd (OMKARPH) share fundamentals

MaterialsCommodity Chemicalsmicro-capNSE / BSE

Omkar Pharmachem Ltd is a micro-cap company in Materials (Commodity Chemicals) with a market capitalisation of ₹6 crore. Here is where it stands on valuation, profitability, debt and growth as of 5 November 2026, and how it compares with the median Materials company.

Share price₹5.95
Market cap₹6 crore
PE ratio50x
ROCE0.5%
Debt / equity0x
1-year return-80%

Financial health score

48
Caution

Out of 100, across five pillars of reported fundamentals.

Profitability35
Debt & solvency100
Valuation33
Growth0
Governance50

What stands out

Omkar Pharmachem Ltd vs the Materials median

MetricOMKARPHSector median
PE ratioprice paid for each rupee of yearly profit50x16.71xWeaker
Price to bookprice against the book value of assets0.16x1.55xBetter
EV / EBITDAbusiness value against operating profit32.11x10.89xWeaker
Dividend yieldyearly dividend as a share of price—0.7%
Return on equityprofit on shareholders’ money0.6%8.4%Weaker
ROCEprofit on all capital employed0.5%11.1%Weaker
Net profit marginprofit kept from each rupee of sales29.2%4.1%Better
Debt to equityborrowing against shareholders’ money0x0.32xBetter
Interest coveragehow many times profit covers interest—4.18x
Current ratioshort-term assets against short-term dues6x1.7xBetter
Revenue growth (1Y)change in sales over a year-11.1%9.5%Weaker
EPS growth (1Y)change in earnings per share over a year-26.3%9.2%Weaker
Promoter holdingshare owned by the founders or parent0%62.2%Weaker
Promoter pledgepromoter shares pledged as loan security0%0%In line
Betahow much it moves with the market—1.05
1-year returnshare price change over 52 weeks-80%-11.6%
Want a plan built around your money?

Tell DecideChart your amount, timeline and target return, and AI builds a full A4 report with risks, scenarios and worst cases. Your first report is free.

Decide · where to investOpen on the chart

Other Materials companies

See all Materials stocks →

Frequently asked questions

What is the PE ratio of Omkar Pharmachem Ltd?

Omkar Pharmachem Ltd trades at a PE of 50x as of 5 November 2026, against a Materials median of 16.71x. PE is the price paid for each rupee of yearly profit.

Is Omkar Pharmachem Ltd debt free?

Omkar Pharmachem Ltd is practically debt free, with a debt-to-equity ratio of 0x.

What is the ROCE and ROE of Omkar Pharmachem Ltd?

Omkar Pharmachem Ltd has a return on capital employed of 0.5% and a return on equity of 0.6%. The Materials medians are 11.1% and 8.4%.

What is the DecideChart health score of Omkar Pharmachem Ltd?

Omkar Pharmachem Ltd scores 48 out of 100, graded Caution. The score weighs profitability, debt, valuation, growth and governance from the company’s reported numbers. It is a research aid, not a recommendation.

Should I buy Omkar Pharmachem Ltd shares?

DecideChart does not give buy or sell tips and is not linked to SEBI, BSE or NSE. Use these numbers for your own research, compare Omkar Pharmachem Ltd with its Materials peers, and consult a SEBI-registered adviser before investing.

Fundamentals from a public market-data screener, as of 5 November 2026. Figures can lag company filings. DecideChart is AI-based, not linked to SEBI, BSE or NSE, and does not give investment advice.